On Nov. 5, former U.S. President Jimmy Carter joined Pfizer Inc. CEO Ian Read at Pfizer headquarters in New York City to celebrate major progress in the global campaign against the blinding disease trachoma as the Center prepares to distribute its 100 millionth dose of Zithromax®, a Pfizer-donated antibiotic used to treat the disease.
On Nov. 5, 2013, former U.S. President Jimmy Carter joined Pfizer CEO Ian Read at Pfizer headquarters in New York to celebrate progress in the international campaign to end blinding trachoma. (Photo: Pfizer/W. Vazquez)
"The Pfizer donation of Zithromax was momentous in trachoma control, and Carterwas pleased to go to scale in trachoma endemic countries to get the medicine into the villages and demonstrate the world could end blinding trachoma," President Carter said during a celebration with partners, nongovernmental organizations (NGOs) and Pfizer employees.
During the last 11 years, Carterhas provided treatments to trachoma-endemic communities in six African countries: Ethiopia, Mali, Nigeria, Niger, Sudan, and South Sudan.
Carterprovides treatments to trachoma-endemic communities in six African countries: Mali, Niger, Nigeria, Sudan, South Sudan, and Ethiopia.
On Nov. 10, the 100 millionth dose of Zithromax® is expected to be distributed in Ethiopia's Amhara region, thought to be one of the most trachoma-endemic areas of the world. The Center, in partnership with the Ethiopia Federal Ministry of Health, local communities, and others including Pfizer and Lions Clubs International Foundation, will celebrate the milestone during MalTra week, an intense effort for widespread treatment and prevention of trachoma and treatment of malaria.
MalTra reaches millions of people each year; the eastern part of Amhara is treated in the spring and the western part is treated in fall.
"Pfizer joins President Carter and others in envisioning a world where blinding trachoma has been eliminated," said Read. "I speak for the entire Pfizer community in reiterating our desire, along with partners like Carterand ITI, to helping end the suffering by 2020," he said.
Related Resources
Please sign up below for important news about the work of Carterand special event invitations.
